Pathway-Directed Therapy in Multiple Myeloma

Pathway-Directed Therapy in Multiple Myeloma

Multiple Myeloma (MM) is a malignant plasma cell disorder with an unmet medical need, in particular for relapsed and refractory patients. Molecules within deregulated signaling pathways, including the RAS/RAF/MEK/ERK, but also the PI3K/AKT-pathway belong to the most promising evolving therapeutic ta...

Full description

Bibliographic Details
Main Authors:	Lukas John, Maria Theresa Krauth, Klaus Podar, Marc-Steffen Raab
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Series:	Cancers
Subjects:	multiple myeloma signaling pathways RAS/RAF/MEK/ERK-pathway PI3K/AKT-pathway BRAF mTOR
Online Access:	https://www.mdpi.com/2072-6694/13/7/1668

Similar Items

ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells
by: Giulia Cesi, et al.
Published: (2017-06-01)

Molecular genetic features of the head and neck (upper aerodigestive tract) mucosal melanoma
by: A V Ignatova
Published: (2016-12-01)

Benzimidazoisoquinoline derivatives inhibit glioblastoma cell proliferation through down-regulating Raf/MEK/ERK and PI3K/AKT pathways
by: Ya-Jun Zhang, et al.
Published: (2018-06-01)

Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell
by: Manping Huang, et al.
Published: (2018-11-01)

Polymorphisms in RAS/RAF/MEK/ERK Pathway Are Associated with Gastric Cancer
by: Patricio Gonzalez-Hormazabal, et al.
Published: (2018-12-01)

In silico authentication of amygdalin as a potent anticancer compound in the bitter kernels of family Rosaceae
by: Zainab Ayaz, et al.
Published: (2020-09-01)

Ras/Raf/MEK/ERK pathway activation in childhood acute lymphoblastic leukemia and its therapeutic targeting
by: Thomas eKnight, et al.
Published: (2014-06-01)

Dexmedetomidine suppresses sevoflurane anesthesia-induced neuroinflammation through activation of the PI3K/Akt/mTOR pathway
by: Nan Wang, et al.
Published: (2019-07-01)

Shengma Biejia Decoction Inhibits Cell Growth in Multiple Myeloma by Inducing Autophagy-Mediated Apoptosis Through the ERK/mTOR Pathway
by: Huibo Dai, et al.
Published: (2021-03-01)

Ras Pathways on Prox1 and Lymphangiogenesis: Insights for Therapeutics
by: Khoa Bui, et al.
Published: (2020-11-01)

Allosteric modulation of Ras and the PI3K/AKT/mTOR pathway: Emerging Therapeutic Opportunities
by: Paul A Hubbard, et al.
Published: (2014-12-01)

Targeting the PI3K/Akt/mTOR pathway in non‐small cell lung cancer (NSCLC)
by: Aaron C. Tan
Published: (2020-03-01)

Metformin represses the pathophysiology of AAA by suppressing the activation of PI3K/AKT/mTOR/autophagy pathway in ApoE−/− mice
by: Zhu Wang, et al.
Published: (2019-08-01)

The Altered Metabolic Molecular Signatures Contribute to the RAD001 Resistance in Gastric Neuroendocrine Tumor
by: Jie Pan, et al.
Published: (2020-04-01)

Downregulation of DEPTOR inhibits the proliferation, migration, and survival of osteosarcoma through PI3K/Akt/mTOR pathway
by: Hu B, et al.
Published: (2017-09-01)

Effects of inhibiting PI3K-Akt-mTOR pathway on lipid metabolism homeostasis in goose primary hepatocytes
by: D.D. Liu, et al.
Published: (2016-01-01)

Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications
by: Wei Liu, et al.
Published: (2020-02-01)

Leonurine Promotes the Osteoblast Differentiation of Rat BMSCs by Activation of Autophagy via the PI3K/Akt/mTOR Pathway
by: Bingkun Zhao, et al.
Published: (2021-02-01)

Ligustrazine Inhibits Growth, Migration and Invasion of Medulloblastoma Daoy Cells by Up-Regulation of miR-211
by: Donghui Xu, et al.
Published: (2018-09-01)

<i>BRAF</i> Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation
by: Izuma Nakayama, et al.
Published: (2020-11-01)

Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention
by: Nazanin Momeni Roudsari, et al.
Published: (2021-08-01)

Development of Dual-Pathway Inhibitors of Raf/MEK/ERK and PI3K/Akt Signaling Pathways.
by: Fraser, Sasha
Published: (2011)

PIM Kinases and Their Relevance to the PI3K/AKT/mTOR Pathway in the Regulation of Ovarian Cancer
by: Aziz Ur Rehman Aziz, et al.
Published: (2018-02-01)

Insulin Stimulates Goose Liver Cell Growth by Activating PI3K-AKT-mTOR Signal Pathway
by: Chunchun Han, et al.
Published: (2016-02-01)

Autophagy—A Hidden but Important Actor on Oral Cancer Scene
by: Totan Alexandra, et al.
Published: (2020-12-01)

Scutellarin inhibits the metastasis and cisplatin resistance in glioma cells
by: Tang S, et al.
Published: (2019-01-01)

Diallyl Disulfide Induces Apoptosis and Autophagy in Human Osteosarcoma MG-63 Cells through the PI3K/Akt/mTOR Pathway
by: Ziqi Yue, et al.
Published: (2019-07-01)

Curcumin suppresses the progression of laryngeal squamous cell carcinoma through the upregulation of miR-145 and inhibition of the PI3K/Akt/mTOR pathway
by: Zhu X, et al.
Published: (2018-06-01)

Cleavage stimulation factor 2 promotes malignant progression of liver hepatocellular carcinoma by activating phosphatidylinositol 3′-kinase/protein kinase B/mammalian target of rapamycin pathway
by: Liu, J., et al.
Published: (2022)

Baicalin suppresses proliferation, migration, and invasion in human glioblastoma cells via Ca2+-dependent pathway
by: Zhu Y, et al.
Published: (2018-10-01)

Ciblage de la voie PI3K/mTOR dans les léiomyosarcomes : sensibilité et mécanismes de résistance
by: Fourneaux, Benjamin
Published: (2017)

Itraconazole exerts anti-liver cancer potential through the Wnt, PI3K/AKT/mTOR, and ROS pathways
by: Wenping Wang, et al.
Published: (2020-11-01)

Application of insulin-like growth factor 1 in the treatment of inner ear disorders
by: Norio eYamamoto, et al.
Published: (2014-09-01)

Insight Into the Role of Autophagy in Osteosarcoma and Its Therapeutic Implication
by: Jianfang Niu, et al.
Published: (2019-11-01)

Rhaponticin suppresses osteosarcoma through the inhibition of PI3K-Akt-mTOR pathway
by: Suresh Mickymaray, et al.
Published: (2021-07-01)

Metformin - its anti-cancer effects in hematologic malignancies
by: Monika Podhorecka
Published: (2021-02-01)

PI3K/Akt/mTOR, a Pathway Less Recognized for Staphylococcal Superantigen-Induced Toxicity
by: Teresa Krakauer
Published: (2012-11-01)

Synaptopodin-2 plays an important role in the metastasis of breast cancer via PI3K/Akt/mTOR pathway
by: Xia E, et al.
Published: (2018-06-01)

Asperolide A, a Marine-Derived Tetranorditerpenoid, Induces G2/M Arrest in Human NCI-H460 Lung Carcinoma Cells, Is Mediated by p53-p21 Stabilization and Modulated by Ras/Raf/MEK/ERK Signaling Pathway
by: Caiguo Huang, et al.
Published: (2013-01-01)

PIM Kinases in Multiple Myeloma
by: Jian Wu, et al.
Published: (2021-08-01)